Patterns of time since last meal revealed by sparse PCA in an observational LC-MS based metabolomics study

Metabolomics

Volumn 9, Issue 5, 2013, Pages 1073-1081

  Gürdeniz, Gözde ^a   Hansen, Louise ^b   Rasmussen, Morten Arendt ^a   Acar, Evrim ^a   Olsen, Anja ^b   Christensen, Jane ^b   Barri, Thaer ^a   Tjønneland, Anne ^b   Dragsted, Lars Ove ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

LC MS; Metabolomics; Observational study; Plasma; SPCA; Time since last meal

Indexed keywords

AMINO ACID; LIPID; LYSOLIPID; UNCLASSIFIED DRUG;

ADULT; AMINO ACID ANALYSIS; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; FOOD INTAKE; HUMAN; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEAL; METABOLITE; METABOLOMICS; OBSERVATIONAL STUDY; PILOT STUDY; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDY; SPARSE PRINCIPAL COMPONENT ANALYSIS; TIME SINCE LAST MEAL;

EID: 84884418656     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0525-x     Document Type: Article

References (28)

1. Acar, E., Gurdeniz, G., Rasmussen, M. A., Rago, D., Dragsted, L. O., & Bro, R. (2012). Coupled matrix factorization with sparse factors to identify potential biomarkers in metabolomics. Proceedings of the 2012 IEEE International Conference on Data Mining Workshops, pp. 1-8.
2. Allen, G. I., & Maletic-Savatic, M. (2011). Sparse non-negative generalized PCA with applications to metabolomics. Bioinformatics, 27, 3029-3035.
3. Barber, M. N., Risis, S., Yang, C., Meikle, P. J., Staples, M., Febbraio, M. A., et al. (2012). Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE, 7, e41456.
4. Barri, T., Holmer-Jensenb, J., Hermansen, K., & Dragsted, L. O. (2012). Metabolic fingerprinting of high-fat plasma samples processed by centrifugation and filtration-based protein precipitation delineates significant differences in metabolite information coverage. Analytica Chimica Acta, 718, 47-57.
5. Bijlsma, S., Bobeldijk, I., Verheij, E. R., Ramaker, R., Kochhar, S., Macdonald, I. A., et al. (2006). Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Analytical Chemistry, 78, 567-574.
6. Boirie, Y., Dangin, M., Gachon, P., Vasson, M. P., Maubois, J. L., & Beaufrere, B. (1997). Slow and fast dietary proteins differently modulate postprandial protein accretion. Proceedings of the National Academy of Sciences of the United States of America, 94, 14930-14935.
7. Chun, H., & Keles, S. (2010). Sparse partial least squares regression for simultaneous dimension reduction and variable selection. Journal of the Royal Statistical Society: Series B: Statistical Methodology, 72, 3-25.
8. Fukagawa, N. K., Minaker, K. L., Rowe, J. W., Goodman, M. N., Matthews, D. E., Bier, D. M., et al. (1985). Insulin-mediated reduction of whole-body protein breakdown-Dose-response effects on leucine metabolism in post-absorptive men. Journal of Clinical Investigation, 76, 2306-2311.
9. Grata, E., Boccard, J., Guillarme, D., Glauser, G., Carrupt, P. A., Farmer, E. E., et al. (2008). UPLC-TOF-MS for plant metabolomics: a sequential approach for wound marker analysis in Arabidopsis thaliana. Journal of Chromatography B, 871, 261-270.
10. Gürdeniz, G., Kristensen, M., Skov, T., & Dragsted, L. O. (2012). The effect of LC-MS data preprocessing methods on the selection of plasma biomarkers in Fed versus fasted rats. Metabolites, 2, 77-99.
11. Han, M. S., Lim, Y. M., Quan, W., Kim, J. R., Chung, K. W., Kang, M., et al. (2011). Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. Journal of Lipid Research, 52, 1234-1246.
12. Krug, S., Kastenmuller, G., Stuckler, F., Rist, M. J., Skurk, T., Sailer, M., et al. (2012). The dynamic range of the human metabolome revealed by challenges. FASEB Journal, 26, 2607-2619.
13. Makide, K., Kitamura, H., Sato, Y., Okutani, M., & Aoki, J. (2009). Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. Prostaglandins and Other Lipid Mediators, 89, 135-139.
14. Pellis, L., van Erk, M. J., van Ommen, B., Bakker, G. C. M., Hendriks, H. F. J., Cnubben, N. H. P., et al. (2012). Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status. Metabolomics, 8, 347-359.
15. Pluskal, T., Castillo, S., Villar-Briones, A., & Oresic, M. (2010). MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics, 11, 395.
16. Rasmussen, M. A., & Bro, R. (2012). A tutorial on the Lasso approach to sparse modeling. Chemometrics and Intelligent Laboratory Systems, 119, 21-31.
17. Rubio-Aliaga, I., de Roos, B., Duthie, S. J., Crosley, L. K., Mayer, C., Horgan, G., et al. (2011). Metabolomics of prolonged fasting in humans reveals new catabolic markers. Metabolomics, 7, 375-387.
18. Schmitz, G., & Ruebsaamen, K. (2010). Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis, 208, 10-18.
19. Sekas, G., Patton, G. M., Lincoln, E. C., & Robins, S. J. (1985). Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. Journal of Laboratory and Clinical Medicine, 105, 190-194.
20. Shaham, O., Wei, R., Wang, T. J., Ricciardi, C., Lewis, G. D., Vasan, R. S., et al. (2008). Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Molecular Systems Biology, 4, 214.
21. Shen, H., & Huang, J. Z. (2008). Sparse principal component analysis via regularized low rank matrix approximation. Journal of Multivariate Analysis, 99(6), 1015-1034.
22. Tjonneland, A., Olsen, A., Boll, K., Stripp, C., Christensen, J., Engholm, G., et al. (2007). Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57, 053 men and women in Denmark. Scandinavian Journal of Public Health, 35, 432-441.
23. Van, D. K., Wilderjans, T. F., van den Berg, R. A., Antoniadis, A., & Van, M. I. (2011). A flexible framework for sparse simultaneous component based data integration. BMC Bioinformatics, 12, 448.
24. Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., et al. (2011). Metabolite profiles and the risk of developing diabetes. Nature Medicine, 17, 448-453.
25. Wold, S., Esbensen, K., & Geladi, P. (1987). Principal Component Analysis. Chemometrics and Intelligent Laboratory Systems, 2, 37-52.
26. Wurtman, R. J., Rose, C. M., Chou, C., & Larin, F. F. (1968). Daily rhythms in the concentrations of various amino acids in human plasma. New England Journal of Medicine, 279, 171-175.
27. Zhao, X., Peter, A., Fritsche, J., Elcnerova, M., Fritsche, A., Haring, H. U., et al. (2009). Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? American Journal of Physiology-Endocrinology and Metabolism, 296, E384-E393.
28. Zou, H., Hastie, T., & Tibshirani, R. (2006). Sparse principal component analysis. Journal of Computational and Graphical Statistics, 15, 265-286.